Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Ovid Therapeutic's purpose is to solve intractable medical problems.
Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.
Unicycive Therapeutics provides development programs that focus on treating kidney diseases with unmet medical needs.
Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.
NAPIGEN is a biotechnology company that addresses novel genome engineering of various organisms such as plants, microbes, and animals.
Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.
Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.
Apeiron labs mission is to provide data from the upper of the ocean.
Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.
Zura Bio is a clinical-stage, multi-asset biotechnology company.
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.
Somatus is a healthcare company that partners with health plans, health systems, nephrology, and primary care groups.
Genetix Biotherapeutics develops and delivers approved gene therapies for severe rare genetic diseases like sickle cell.
MMI is focused on advancing robotic technology for soft tissue open surgery with the world's smallest wristed instruments.
Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.
Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.
Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.
Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.
Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.
Abcuro develops immunotherapies to treat autoimmunity and cancer.
Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.
Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.
RA Capital Management has invested in 453 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Health Care, Medical, Biopharma, Life Science. The firm invests across 25 different industry categories.
Among tracked funding rounds, Dianthus Therapeutics received $719.0M in a Post-IPO Equity round. RA Capital Management's total known invested capital is $44.2B.
RA Capital Management's average investment size is $123.1M across its portfolio of 453 companies.
Recent RA Capital Management portfolio additions include Ovid Therapeutics, Curevo, Unicycive Therapeutics, Equillium, Napigen. These companies were founded in 2020 or later.